NOTIFICATION OF ISSUE OF SECURITIES
Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)
NOTIFICATION OF ISSUE OF SECURITIES
Auckland, New Zealand, 28 February 2017 - Fisher & Paykel Healthcare Corporation Limited
(NZSX:FPH, ASX:FPH) advises that the following securities were issued pursuant to the
Company’s 2012 and 2013 issue of options under the Fisher & Paykel Healthcare 2003 Share
Option Plan. The issue of options and shares under the Option Plan was approved by the Board
on 22 August 2012 and 27 August 2013 respectively.
(a) Class of security Ordinary shares
ISIN NZFAPE0001S2
(b) Number issued 14,896
(c) Issue price $2.06 (12,500 shares); $3.57 (2,396 shares)
(d) Payment terms Nil refer (g) below
(e) Amount paid up In full
(f) Percentage of total class issued 0.00262%
(g) Reason for issue Employee cancelling options issued under the 2013
issue of the Fisher & Paykel Healthcare 2003 Share
Option Plan.
4,020 options were cancelled on 28 February 2017
pursuant to the Cancellation Offer approved by
shareholders at the ASM held on 12 August 2004.
2,396 shares were issued in consideration of the
cancellation of the options and are equal in value to the
gain on the options (such gain being calculated based
on an exercise price of $3.57).
12,500 shares were issued to an employee exercising
options issued under the 2012 issue of the Fisher &
Paykel Healthcare 2003 Share Option Plan based on
an exercise price of $2.06.
(h) Authority for issue Directors’ resolution
(i) Terms of issue The shares rank pari passu with the existing ordinary
shares.
(j) Total number of securities after
issue
567,484,875
(l) Date of issue 28 February 2017
This advice is given under Listing Rule 7.12.1.
Ends
Contact: Tony Barclay, Company Secretary on +64 9 574 0119. For more information about the
company visit our website www.fphcare.com
---
+ See chapt er 1 9 f or def i ned t er ms.
04/ 03/ 2013 A ppendix 3 B Page 1
Rul e 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement,
application for quotation of additional securities
and agreement
I nfor mati on or documents not avai l abl e now must be gi ven to ASX as soon as avai l abl e. I nfor mati on and
documents gi ven to ASX become ASX’ s pr oper ty and may be made publ i c.
Introduced 01/ 07/ 96 O rigin: A ppendix 5 A mended 01/ 07/ 98, 01/ 09/ 99, 01/ 07/ 00, 30/09/ 01, 11/03/ 02, 01/ 01/ 03,
24/ 10/ 05, 01/ 08/ 12, 04/ 03/ 13
N ame of ent i t y
Fisher & Paykel Healthcare Corporation Limited
A BN
098 026 281
We ( t he ent i t y) gi ve A SX t he f ol l owi ng i nf or mat i on.
Part 1 - All issues
You must compl ete the r el evant secti ons (attach sheets i f ther e i s not enough space).
1
+
C l ass o f
+
sec u r i t i es i ssu ed o r t o
b e i ssu ed
Ordinary Shares
2 Number of
+
sec u r i t i es i ssu ed o r
t o be issued ( if known) or
maximum number which may be
i ssu ed
14,896
3 Principal terms of the
+
sec u r i t i es
(e.g. i f opt i ons, exer ci se pr i ce
and expiry date; if partly paid
+
securit ies, t he amount
out st anding and due dates for
payment; if
+
conver t i bl e
secur i t i es, t he conver si on pr i ce
and dates for conversion)
I ssu e o f 2,396 fully paid ordinary shares
following cancellation of 4,020 options
gr ant ed under t he Fi sher & Paykel
Healthcare Share O ption Plan in Sept ember
2013.
T he shar es wer e i ssued i n consi der at i on of
the cancellation of the options and are equal
in value to the gain on the options ( such
gai n bei ng cal cul at ed based on an exer ci se
price of $3.57).
Issue of 12,500 fully paid ord i n ar y sh ar es
following exercise of 12,500 options
gr ant ed under t he Fi sher & Paykel
Healthcare O ption Plan in A ugust 2 0 1 2
based on an exer ci se pr i ce of $ 2 . 0 6 .
4 Do t he
+
securit ies rank equally
i n al l r espect s f r om t he
+
i ssu e
d at e wi t h an exi st i ng
+
cl ass of
quot ed
+
sec u r i t i es?
If the additional
+
sec u r i t i es d o
no t r ank equal l y , p l ease st at e:
• t he dat e from which t hey do
• t he ext ent t o which t hey
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
• the extent to which t hey do
not rank equally, ot her t han
in relat ion t o t he next
dividend, distribution or
i nt er est payment
Yes
5 Issue price or consideration
NZD3.57 (A U D3 .35) per ordinary share -
2,396 sh ar es.
NZD2.06 (AUD1.93) per ordinary share -
12,500 shar es
+ See chapt er 1 9 f or def i ned t er ms.
04/ 03/ 2013 A ppendix 3 B Page 3
6 Pu r p o se o f t h e i ssu e
(If issued as consideration for the
acquisition of assets, clearly
i d en t i f y t h o se asset s)
Issued to employees under the ‘‘Fi sh er &
Paykel H ealthcare 2003 Share Option Plan’’
- -- 14,896 sh ar es.
6a Is t he ent it y an
+
eligible entity
t hat has obt ained securit y holder
approval under rule 7.1A ?
I f Yes, compl et e sect i ons 6 b - --
6 h i n r el ati on to the
+
secur i t i es
the subj ect of thi s Appendi x 3B,
and comply with section 6 i
No
6b T he dat e t he secur i t y hol der
resolut ion under rule 7 .1 A was
p assed
6c N umber of
+
sec u r i t i es i ssu ed
without security holder approval
under rule 7 .1
6d N umber of
+
sec u r i t i es i ssu ed
with security holder approval
under rule 7 .1A
6e N umber of
+
sec u r i t i es i ssu ed
with security holder approval
under rule 7 .3 , or anot her
specific security holder approval
( speci f y dat e of meet i ng)
6f N umber of
+
sec u r i t i es i ssu ed
under an except ion in rule 7 .2
6g If
+
securities issued under rule
7 . 1 A , w as i ssu e p r i c e at l east
75% of 15 day VWAP as
calculat ed under rule 7 .1 A .3 ?
Include t he
+
issue dat e and bot h
v al u es. Include t he source of t he
V WA P calculation.
6h If
+
secur i t i es wer e i ssued under
rule 7 .1 A for non-c ash
cons
ideration, state date on
which valuat ion of considerat ion
was r el eased t o A SX M ar ket
A nnouncement s
6i Cal cul at e t he ent i t y’ s r emai ni ng
issue capacit y under rule 7 .1 and
rule 7.1A - -- compl et e A nnexur e
1 and r el ease t o A SX M ar ket
A nnouncement s
7
+
I ssu e dat es
N ot e: The i ssue dat e may be pr escr i bed by
A SX ( r ef er t o t he def i ni t i on of i ssue dat e i n
r ul e 1 9 . 1 2 ) . For exampl e, t he i ssue dat e f or a
pro rata entitlement issue must comply with
the applicable timetable in A ppendix 7A .
Cr oss r ef er ence: i t em 33 of A ppendix 3B.
28 Febr uar y 2017
N umber
+
C l ass
8 N umber and
+
class of all
+
securit ies quot ed on A SX
(i ncl udi ng t he
+
securities in
sec t i o n 2 if applicable)
567,484,875 Ordinary Shares
+ See chapt er 1 9 f or def i ned t er ms.
04/ 03/ 2013 A ppendix 3 B Page 5
Part 2 - Pro rata issue
9 Number and +class of all
+securities not quoted on
ASX (including the
securities in clause 2 if
applicable
Number Class
FPHAJ 395,160 PSRs expiring 6 September
2021, NZ$Nil exercise price.
FPHAH 459,260 PSRs expiring 8 September
2020, NZ$Nil exercise price.
FPHAF 554,170 PSRs expiring 28 August 2019,
NZ$Nil exercise price.
FPHAD 2,530 PSRs expiring 4 September
2018, NZ$Nil exercise price.
FPHAB 1,216,727 Options expiring 6 September
2021, exercise price NZ$9.82.
FPHAI 35,480 Options expiring 11 September
2020, exercise price NZ$7.23.
FPHAG 1,219,100 Options expiring 8 September
2020, exercise price NZ$7.23.
FPHAE 1,453,190 Options expiring 28 August 2019,
exercise price NZ$4.88.
FPHAC 1,541,910 Options expiring 4 September
2018, exercise price NZ$3.57.
FPHAS 1,078,150 Options expiring 30 August 2017,
exercise price NZ$2.06.
10 Dividend policy (in the case of a
t rust , dist ribut ion policy) on t he
i ncr eased capi t al ( i nt er est s)
N o change
11 Is security holder approval
r equi r ed?
12 I s t he issue renounceable or non-
renounceable?
13 Rat io in which t he
+
securities will
be of f er ed
14
+
C l ass o f
+
securit ies t o which t he
of f er r el at es
15
+
Record date to determine
ent i t l ement s
16 Will holdings on different registers
(or subr egi st er s) be aggr egat ed
for calculating entitlements?
17 Policy for deciding entitlements in
relation to fractions
18 N ames of count ries in which t he
ent it y has securit y holders who
will not be sent new offer
documents
N ot e: Secur i t y holders must be told how their
ent i t l ement s ar e t o be deal t wi t h.
Cr oss r ef er ence: r ul e 7 . 7 .
19 Closing date for receipt of
accept ances or renunciat ions
+ See chapt er 1 9 f or def i ned t er ms.
04/ 03/ 2013 A ppendix 3 B Page 7
20 N ames of any under wr i t er s
21 A mount of any underwrit ing fee
or commission
22 N am es o f an y b r o k er s t o t h e i ssu e
23 Fee or commission payable to the
broker t o t he issue
24 A mount of any handling fee
payable to brokers who lodge
accept ances or renunciat ions on
behalf of securit y holders
25 If t he issue is cont ingent on
security holders’ approval, the
dat e of t he meet i ng
26 Dat e ent i t l ement and accept ance
form and offer documents will be
sent t o per sons ent i t l ed
27 If t he ent it y has issued opt ions,
and the terms entitle option
holders to participate on exer ci se,
t he dat e on which not ices will be
sent to option holders
28 Date rights trading will begin (if
applicable)
29 Date rights trading will end (if
applicable)
30 How do security holders sell their
ent i t l ement s i n ful l t hrough a
broker ?
31 How do security holders sell par t
of t heir ent it lement s t hrough a
broker and accept for the
bal ance?
+ See chapt er 1 9 f or def i ned t er ms.
A ppendi x 3 B Page 8 04/ 03/ 2013
32 How do security holders dispose
of t hei r ent i t l ement s ( except by
sale t hrough a broker) ?
33
+
I ssu e d at e
Part 3 - Quotation of securities
You need onl y compl ete thi s secti on i f you ar e appl yi ng for quotati on of secur i ti es
34 Type of
+
secur i t i es
(ti ck one)
( a)
+
Secur i t i es descr i bed i n Par t 1
( b)
A ll other
+
secur i t i es
Exampl e: r estricted securities at the end of the escrowed period, partly paid securities that become fully paid,
empl oyee i ncent i ve shar e secur i t i es when r est r i ct i on ends, secur i t i es i ssued on expi r y or conver si on of conver t i bl e
secur i t i es
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Ti ck to i ndi cate you ar e pr ovi di ng the i nfor mati on or
documents
35
If the
+
secur i t i es ar e
+
equi t y secur i t i es, t he names of t he 2 0 l ar gest hol der s of t he
additional
+
securit ies, and t he number and percent age of addit ional
+
sec u r i t i es
held by t hose holders
36
If the
+
secur i t i es ar e
+
equit y securit ies, a dist ribut ion schedule of t he addit ional
+
securit ies set t ing out t he number of holders in t he cat egor i es
1 - 1,000
1,001 - 5,000
5,001 - 10,000
10,001 - 100,000
100,001 and over
37
A copy of any trust deed for the additional
+
secur i t i es
+ See chapt er 1 9 f or def i ned t er ms.
04/ 03/ 2013 A ppendix 3 B Page 9
Entities that have ticked box 34(b)
38 N umber of
+
securit ies for which
+
quot at ion is sought
39
+
C l ass o f
+
securit ies for which
quot at ion is sought
40 Do t he
+
securit ies rank equally in
al l r espect s f r om t he
+
i ssu e d at e
wit h an exist ing
+
class of quoted
+
sec u r i t i es?
If the additional
+
securities do not
r ank equal l y , p l ease st ate:
• t he dat e from which t hey do
• t he ext ent t o which t hey
participate for the next
dividend, (in the case of a
trust, distribution) or interest
payment
• t he ext ent t o which t hey do
not rank equally, ot her t han in
relation to the next dividend,
dist ribut ion or i nt er est
payment
41 Reason for request for quot at ion
now
Exampl e: I n t he case of r est r i ct ed secur i t i es, end
of restriction period
(if issued upon conversion of
anot her
+
security, clearly identify
that other
+
sec u r i t y )
N umber
+
C l ass
42 Number and
+
class of all
+
securit ies quot ed on A SX
(i ncl udi ng t he
+
securities in clause
38)
+ See chapt er 1 9 f or def i ned t er ms.
A ppendi x 3 B Page 10 04/ 03/ 2013
Quot at i on agr eement
1
+
Q uotation of our additional
+
securities is in A SX’s absolute discretion. A SX
may quote the
+
securities on any conditions it decides.
2 We war r ant t he f ol l owi ng t o A SX .
• T he i ssue of t he
+
securities to be quoted complies with the law and is
not for an illegal purpose.
• There is no reason why those
+
securities should not be granted
+
quotation.
• A n offer of the
+
sec u r i t i es f o r sale within 1 2 months after their issue
will not require disclosure under section 7 0 7 ( 3 ) or section 1012C(6)
of the Corporations A ct.
N ote: A n entity may need to obtain appropriate warranties from subscribers for the securities in order to be able
t o gi ve t hi s war r ant y
• Section 724 or section 1016E of the Corporations A ct does not apply
to any applications received by us in relation to any
+
secur i t i es t o be
quoted and that no-one has any right to return any
+
secur i t i es t o be
quoted under sections 7 3 7 , 7 38 or 1016F of the Corporations A ct at
the time that we request that the
+
secur i t i es be quot ed.
• If we are a trust, we warrant that no person has the right to return the
+
securities to be quoted under section 1019B of the Corporations A ct
at the time that we r equest t hat t he
+
secur i t i es be quot ed.
3 We wi l l i ndemni f y A SX t o t he f ul l est ext ent per mi t t ed by l aw i n r espect of any
claim, action or expense arising from or connected with any breach of the
war r ant i es i n t hi s agr eement .
4 We gi ve A SX t he i nf or mation and documents required by this form. If any
information or document i s no t avai l abl e no w, we will give it to A SX before
+
quotation of the
+
secur i t i es begi ns. We acknowl edge t hat A SX i s r el yi ng on
the information and documents. We warrant that they ar e ( wi l l be) t r ue and
compl et e.
Si gn her e: ................................................ Dat e: 28 Febr uar y 2017
Company Secr et ar y
Print name: A nt o ny G . Bar cl ay
== == == == ==
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.